Pharmaceutical Preparations Annual report
Alnylam (NASDAQ: ALNY)
ALNYLAM PHARMACEUTICALS, INC.
Industry: Pharmaceutical
| Period | Opening price | Closing price | Growth rate | Report date |
|---|---|---|---|---|
| 2025Q3 | 2025-10-30 |
$ALNY Quarterly report
$ALNY Annual report
$ALNY Assets
BIOMARIN (NASDAQ: BMRN)
BioMarin Pharmaceutical Inc.
BIOMARIN PHARMACEUTICAL INC
Industry: Biotechnology
$BMRN Annual report


Catalent (NYSE: CTLT)
Catalent, Inc.
(Catalent Pharma Solutions)
Industry: Pharmaceuticals
Fiscal year end: June 30
Date = FiscalDate - 6m
$CTLT Annual report

BIOMARIN (NASDAQ: INSM)
INSMED INCORPORATED
INSMED Inc
Industry:
$INSM Quarterly report
$INSM Annual report
$INSM Assets
Intra-Cellular (NASDAQ: ITCI)
Intra-Cellular Therapies, Inc.
Industry:

$ITCI Quarterly report

$ITCI Annual report


ROYALTY PHARMA (NASDAQ: RPRX)
Royalty Pharma plc
United Kingdom
Industry:
$RPRX Annual report


Summit (NASDAQ: SMMT)
Summit Therapeutics Inc.
Industry:

$SMMT Annual report
SAREPTA THERAPEUTICS (NASDAQ: SRPT)
SAREPTA THERAPEUTICS, INC.
Sarepta Therapeutics, Inc.
Industry:

$SRPT Annual report


teva (NYSE: TEVA)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (also known as Teva Pharmaceuticals)
TEVA PHARMACEUTICAL INDUSTRIES LTD
Israel
Industry: Pharmaceutical
Some rounding errors in the BS, IS, SOCF have been corrected.

$TEVA Annual report

United Therapeutics (NASDAQ: UTHR)
United Therapeutics Corporation
UNITED THERAPEUTICS Corp
Industry: Biotechnology
$UTHR Quarterly report
$UTHR Annual report
$UTHR Assets
VIATRIS (NASDAQ: VTRS)
VIATRIS INC.
Viatris Inc
Industry: Pharmaceuticals, Healthcare

$VTRS Annual report


(NASDAQ: RPRX) Annual report 2024
ردحذف(NASDAQ: BMRN) Current (Annual) report 2024
ردحذف(NASDAQ: VTRS) Annual report 2024
ردحذف(NASDAQ: SRPT) Annual report 2024
ردحذف(NASDAQ: ITCI) Annual report 2024
ردحذف(NASDAQ: UTHR) Quarterly report 2025Q3
ردحذف(NASDAQ: ALNY) Quarterly report 2025Q3
ردحذف(NASDAQ: INSM) Quarterly report 2025Q3
ردحذفإرسال تعليق